Pedder Simon
SEC-identified person · CIK 1316736 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Unite Acquisition 1 Corp. | Director · Executive Chairman | filed 2025–2025 |
| Athenex, Inc. ATNX | See Remarks. | filed 2017–2021 |
| Cerecor Inc. CERC | Director · Executive Chairman of the Bd | filed 2018–2020 |
| Delcath Systems, INC. DTCH | Director | filed 2019–2019 |
| Oncotelic Therapeutics, Inc. OXGN | Director | filed 2016–2018 |
| Cellectar Biosciences, Inc. clrB | Director · President and CEO | filed 2014–2014 |
| Chelsea Therapeutics International, Ltd. CHTP.OB | Director · Chief Executive Officer | filed 2006–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.